- Ortho's new VITROS ® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians ...
(RTTNews) - Vitro diagnostics company Ortho Clinical Diagnostics (OCDX) announced Tuesday that it received authorization from the U.S. Food and Drug Administration (FDA) to update key claims for the ...
RARITAN, N.J., July 7, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play, in-vitro diagnostics (IVD) companies, today announced its distribution agreement ...
RARITAN, N.J., July 22, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced its VITROS (R) ...
Raritan-based Ortho Clinical Diagnostics said July 9 that its VITROS Anti-SARS-CoV-2 IgG Quantitative Test is the first quantitative COVID-19 IgG antibody test to receive U.S. Food and Drug ...
(RTTNews) - Ortho Clinical Diagnostics (OCDX) said it received CE Marking for VITROS SARS-CoV-2 Antigen Test. The company noted that the CE Mark allows for more convenient sample collection and ...